Viewing StudyNCT00492050



Ignite Creation Date: 2024-05-05 @ 5:36 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00492050
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-15
First Post: 2007-06-26

Brief Title: Bortezomib and Rituximab for Patients With Waldenstroms Macroglobulinemia
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Waldenstroms Macroglobulinemia
Keywords:
Name View
Rituxan View
Waldenstroms Macroglobulinemia View
Macroglobulinemic Lymphoma View
Stem Cell Collection View
Bortezomib View
LDP-341 View
MLN341 View
PS-341 View
Velcade View
Rituximab View